Dr Reddy's Laboratories Ltd
NSE:DRREDDY

Watchlist Manager
Dr Reddy's Laboratories Ltd Logo
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Watchlist
Price: 5 799.55 INR -0.51% Market Closed
Updated: May 19, 2024

Dr Reddy's Laboratories Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dr Reddy's Laboratories Ltd
Operating Income Peer Comparison

Comparables:
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
M
MANKIND

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Operating Income
₹64.6B
CAGR 3-Years
25%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Operating Income
₹52.4B
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
12%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Operating Income
₹101.5B
CAGR 3-Years
20%
CAGR 5-Years
13%
CAGR 10-Years
5%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Operating Income
₹39.1B
CAGR 3-Years
16%
CAGR 5-Years
10%
CAGR 10-Years
15%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Operating Income
₹24.1B
CAGR 3-Years
10%
CAGR 5-Years
14%
CAGR 10-Years
13%
M
Mankind Pharma Ltd
NSE:MANKIND
Operating Income
₹21.4B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Dr Reddy's Laboratories Ltd's Operating Income?
Operating Income
64.6B INR

Based on the financial report for Mar 31, 2024, Dr Reddy's Laboratories Ltd's Operating Income amounts to 64.6B INR.

What is Dr Reddy's Laboratories Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
26%

Over the last year, the Operating Income growth was 22%. The average annual Operating Income growth rates for Dr Reddy's Laboratories Ltd have been 25% over the past three years , 26% over the past five years .